Nabors, Gary S.Afonso, Luís Carlos CroccoFarrell, Jay P.Scott, Phillip2015-03-132015-03-131995NABORS, G. S. et al. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proceedings of the National Academy of Sciences of the United States of America, v. 92, n.4, p. 3142-3146, 1995. Disponível em: <http://www.pnas.org/content/92/8/3142.full.pdf+html>. Acesso em: 08 nov. 2014.1091-6490http://www.repositorio.ufop.br/handle/123456789/4631Successful treatment in allergic, autoimmune, and infectious diseases often requires altering the nature of a detrimental immune response mediated by a particular CD4+ T helper (Th) cell subset. While several factors contribute to the development of CD4+ Thi and Th2 cells, the requirements for switching an established response are not understood. Here we use infection with Leishmania major as a model to investigate those requirements. We report that treatment with interleukin 12 (IL-12), in combination with the antimony-based leishmanicidal drug Pentostam, induces healing in L. major-infected mice and that healing is associated with a switch from a Th2 to a Thl response. The data suggest that decreasing antigen levels may be required for IL-12 to inhibit a Th2 response and enhance a Thi response. These observations are important for treatment of nonhealing forms of human leishmaniasis and also demonstrate that in a chronic infectious disease an inappropriate Th2 response can be switched to an effective Thi response.en-USAntimonyChronic infectionArtigo publicado em periodicoBeginning with articles submitted in Volume 106 (2009) the author(s) retains copyright to individual articles published in PNAS. Fonte: PNAS_ Proceedings of the National Academy of Sciences of the United States of America <http://www.pnas.org/site/aboutpnas/rightperm.xhtml>. Acesso em: 13 out. 2016.https://doi.org/10.1073/pnas.92.8.3142